Sensory ion channels TRPC3 and TRPC7 could be the potential therapeutic targets in pancreatic cancer and TRPC3 might be involved in dysregulating mitochondrial functions during pancreatic adenocarcinoma genesis. This evidence concerns the gene TRPC3 and familial pancreatic carcinoma.